Stoke Therapeutics, Inc. (STOK)
28.88
+0.40
(+1.40%)
USD |
NASDAQ |
Jun 11, 11:33
Stoke Therapeutics SG&A Expense (Quarterly) : 19.97M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 19.97M |
| December 31, 2025 | 21.15M |
| September 30, 2025 | 16.03M |
| June 30, 2025 | 15.26M |
| March 31, 2025 | 14.65M |
| December 31, 2024 | 12.84M |
| September 30, 2024 | 12.69M |
| June 30, 2024 | 13.04M |
| March 31, 2024 | 10.22M |
| December 31, 2023 | 10.61M |
| September 30, 2023 | 10.27M |
| June 30, 2023 | 10.23M |
| March 31, 2023 | 10.21M |
| December 31, 2022 | 9.383M |
| September 30, 2022 | 9.944M |
| June 30, 2022 | 10.11M |
| March 31, 2022 | 9.486M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.724M |
| September 30, 2021 | 8.325M |
| June 30, 2021 | 7.934M |
| March 31, 2021 | 6.914M |
| December 31, 2020 | 5.682M |
| September 30, 2020 | 5.602M |
| June 30, 2020 | 5.044M |
| March 31, 2020 | 4.52M |
| December 31, 2019 | 3.979M |
| September 30, 2019 | 3.324M |
| June 30, 2019 | 2.422M |
| March 31, 2019 | 2.189M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.66M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 34.59M |
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |
| Imunon, Inc. | 1.969M |